Aurora Achieves Significant Progress in Disease Resistance Research
Newswire.ca - Wed Jan 14, 6:00AM CST
NASDAQ| TSX: ACB
As a leading global medical cannabis company, advancements in breeding, testing and production trials for powdery mildew-resistant cultivars reinforce Aurora's leadership in cannabis science
Read more at newswire.caThis article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.